Clinical Trial

A Prospective Cohort Study of Basivertebral Nerve Ablation Using the Stryker OptaBlate BVN System for the Treatment of Vertebrogenic Low Back Pain

Study acronym: OptaBlate BVN
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to evaluate patient outcomes following treatment of vertebrogenic low back pain using the Stryker OptaBlate BVN System. Patients treated in accordance with the device IFU as part of routine clinical care and who consent to participate will be followed for 12 months after the procedure to assess treatment outcomes.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-06-19
notable Primary completion pushed: 2026-12-31 -> 2027-01-31 2026-06-19
Trial Details
NCT Number NCT07392333
Lead Sponsor Stryker Instruments
Conditions Verteborgenic Low Back Pain, Back Pain Lower Back
Enrollment 25 participants
Start Date 2026-06-02
Primary Completion 2027-01-31 (estimated)
Study Completion 2027-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-18